{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T18:50:59Z","timestamp":1792263059383,"version":"4.4.0"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000193","name":"International Development Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biotechnology Advances"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.biotechadv.2020.107608","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T11:42:14Z","timestamp":1596627734000},"page":"107608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"special_numbering":"C","title":["Vero cell upstream bioprocess development for the production of viral vectors and vaccines"],"prefix":"10.1016","volume":"44","author":[{"given":"Sascha","family":"Kiesslich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amine A.","family":"Kamen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biotechadv.2020.107608_bb0005","article-title":"Variable selection and parameter estimation of viral amplification in vero cell cultures dedicated to the production of a dengue vaccine","author":"Abbate","year":"2018","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/9780471729259.mca04es11","article-title":"Growth and maintenance of vero cell lines","volume":"11","author":"Ammerman","year":"2008","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0015","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/586363","article-title":"Production of Newcastle disease virus by vero cells grown on cytodex 1 microcarriers in a 2-litre stirred tank bioreactor","volume":"2010","author":"Arifin","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0020","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.1016\/j.vaccine.2015.06.110","article-title":"Cell substrates for the production of viral vaccines","volume":"33","author":"Aubrit","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0025","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1586\/erv.09.19","article-title":"Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines","volume":"8","author":"Barrett","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0030","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/14760584.2017.1357471","article-title":"Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases","volume":"16","author":"Barrett","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0035","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1016\/j.vaccine.2020.03.041","article-title":"Development of a high-yield live-virus vaccine production platform using a novel fixed-bed bioreactor","volume":"38","author":"Berrie","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1097-0290(19990105)62:1<12::AID-BIT2>3.0.CO;2-G","article-title":"Production of reovirus type-1 and type-3 from vero cells grown on solid and macroporous microcarriers","volume":"62","author":"Berry","year":"1999","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-4-23","article-title":"Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4\u039430 with those of DEN1","volume":"4","author":"Blaney","year":"2007","journal-title":"Virol. J."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0050","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/bit.20873","article-title":"Intracellular ATP and total adenylate concentrations are critical predictors of reovirus productivity from vero cells","volume":"94","author":"Burgener","year":"2006","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0055","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1021\/bp000110+","article-title":"Application of a serum-free medium for the growth of Vero cells and the production of reovirus","volume":"16","author":"Butler","year":"2000","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0060","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/infdis\/jit123","article-title":"Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC\/2012: implications for disease pathogenesis and clinical manifestation","volume":"207","author":"Chan","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0065","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6750-11-81","article-title":"Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells","volume":"11","author":"Chen","year":"2011","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mSphere.00298-19","article-title":"Adventitious virus detection in cells by high-throughput sequencing of newly synthesized RNAs: unambiguous differentiation of cell infection from carryover of viral nucleic acids","volume":"4","author":"Cheval","year":"2019","journal-title":"mSphere"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0075","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/S0264-410X(03)00005-7","article-title":"Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells","volume":"21","author":"Choi","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0080","doi-asserted-by":"crossref","first-page":"14802","DOI":"10.1073\/pnas.0905912106","article-title":"Conversion of MDCK cell line to suspension culture by transfecting with human siat7e gene and its application for influenza virus production","volume":"106","author":"Chu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0085","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1021\/bp960086t","article-title":"Optimization of an assay for baculovirus titer and design of regimens for the synchronous infection of insect cells","volume":"13","author":"Dee","year":"1997","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bej.2012.11.001","article-title":"Impact of microcarrier coverage on using permittivity for on-line monitoring high adherent Vero cell densities in perfusion bioreactors","volume":"70","author":"El-Wajgali","year":"2013","journal-title":"Biochem. Eng. J."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1099\/0022-1317-43-1-247","article-title":"Regulation of the interferon system: evidence that vero cells have a genetic defect in interferon production","volume":"43","author":"Emeny","year":"1979","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0168-1656(01)00362-5","article-title":"Higher production of rabies virus in serum-free medium cell cultures on microcarriers","volume":"92","author":"Frazatti-Gallina","year":"2001","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0105","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.vaccine.2016.04.031","article-title":"Evaluation of Vero-cell-derived simian endogenous retrovirus infection in humans by detection of viral genome in clinicopathological samples and commercialized vaccines and by serology of Japanese general population","volume":"34","author":"Fukumoto","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0110","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1586\/14760584.2015.1067144","article-title":"Bioreactor concepts for cell culture-based viral vaccine production","volume":"14","author":"Gallo\u2013Ram\u00edrez","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0115","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/infdis\/jir349","article-title":"Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections","volume":"204","author":"Geisbert","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0120","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/biot.201400388","article-title":"Designing cell lines for viral vaccine production: where do we stand?","volume":"10","author":"Genzel","year":"2015","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00253-010-2742-9","article-title":"MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation","volume":"88","author":"Genzel","year":"2010","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0130","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/btpr.2432","article-title":"Screening different host cell lines for the dynamic production of measles virus","volume":"33","author":"Grein","year":"2017","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0135","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/bit.26538","article-title":"High titer oncolytic measles virus production process by integration of dielectric spectroscopy as online monitoring system","volume":"115","author":"Grein","year":"2018","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fbioe.2019.00078","article-title":"Aeration and shear stress are critical process parameters for the production of oncolytic measles virus","volume":"7","author":"Grein","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0145","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.vaccine.2018.03.010","article-title":"Enhancing viral vaccine production using engineered knockout vero cell lines \u2013 a second look","volume":"36","author":"Hoeksema","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ymben.2006.12.001","article-title":"Application of microarrays to identify and characterize genes involved in attachment dependence in HeLa cells","volume":"9","author":"Jaluria","year":"2007","journal-title":"Metab. Eng."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0155","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.procbio.2019.03.010","article-title":"Kinetic model for adherent Vero cell growth and poliovirus production in batch bioreactors","volume":"81","author":"Jiang","year":"2019","journal-title":"Process Biochem."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0160","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jbiotec.2020.01.015","article-title":"Serum-free production of rVSV-ZEBOV in Vero cells: microcarrier bioreactor versus scale-X TM hydro fixed-bed","volume":"310","author":"Kiesslich","year":"2020","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0165","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0264-410X(97)00301-0","article-title":"Development of a mammalian cell (Vero) derived candidate influenza virus vaccine","volume":"16","author":"Kistner","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0170","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1016\/j.vaccine.2007.01.103","article-title":"The preclinical testing of a formaldehyde inactivated Ross River virus vaccine designed for use in humans","volume":"25","author":"Kistner","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0175","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/bp060373p","article-title":"Bioreactor production of recombinant herpes simplex virus vectors","volume":"23","author":"Knop","year":"2007","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0180","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jbiosc.2010.12.018","article-title":"Growth and poliovirus production of Vero cells on a novel microcarrier with artificial cell adhesive protein under serum-free conditions","volume":"111","author":"Kurokawa","year":"2011","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0185","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.omtm.2019.08.006","article-title":"Preclinical proof-of-concept, analytical development, and commercial scale production of lentiviral vector in adherent cells","volume":"15","author":"Leinonen","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0190","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/hum.2015.081","article-title":"Process development of adenoviral vector production in fixed bed bioreactor: from bench to commercial scale","volume":"26","author":"Lesch","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0195","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.virol.2007.12.021","article-title":"Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine","volume":"374","author":"Lim","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-7506-0421-5.50096-9","article-title":"The growth of Vero cells as suspended aggregates in serum-free medium","author":"Litwin","year":"1992","journal-title":"Anim. Cell Technol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vaccine.2006.06.083","article-title":"High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture","volume":"25","author":"Liu","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001810","article-title":"High genetic stability of dengue virus propagated in MRC-5 cells as compared to the virus propagated in vero cells","volume":"3","author":"Liu","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0215","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1016\/j.vaccine.2017.02.042","article-title":"Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture","volume":"36","author":"Liu","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0220","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.1128\/JVI.00147-11","article-title":"Chemical induction of endogenous retrovirus particles from the Vero cell line of African Green monkeys","volume":"85","author":"Ma","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0225","series-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","first-page":"727","author":"Ma","year":"2020"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0230","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1016\/j.vaccine.2015.04.050","article-title":"Increasing Vero viable cell densities for yellow fever virus production in stirred-tank bioreactors using serum-free medium","volume":"33","author":"Mattos","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0235","doi-asserted-by":"crossref","first-page":"69","DOI":"10.18869\/acadpub.vacres.2.4.69","article-title":"Comparison of Vero and MDCK cell lines transfected with human siat7e gene for conversion to suspension culture","volume":"2","author":"Mehrbod","year":"2015","journal-title":"Vaccine Res."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0240","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00369503","article-title":"High density VERO cell culture on microcarriers in a cell bioreactor","volume":"12","author":"Mendon\u00e7a","year":"1995","journal-title":"Bioprocess Eng."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0245","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s004490050433","article-title":"Cell metabolism and medium perfusion in VERO cell cultures on microcarriers in a bioreactor","volume":"18","author":"Mendon\u00e7a","year":"1998","journal-title":"Bioprocess Eng."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0250","first-page":"1305","article-title":"Preparation of human rabies vaccine in VERO cell culture using a microcarrier system","volume":"26","author":"Mendonca","year":"1993","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0255","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s004490050630","article-title":"Attachment, spreading and growth of VERO cells on microcarriers for the optimization of large scale cultures","volume":"20","author":"Mendon\u00e7a","year":"1999","journal-title":"Bioprocess Eng."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0168-1656(02)00048-2","article-title":"Metabolic active-high density VERO cell cultures on microcarriers following apoptosis prevention by galactose\/glutamine feeding","volume":"97","author":"Mendon\u00e7a","year":"2002","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0265","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00772195","article-title":"Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: use of various cell lines","volume":"14","author":"Merten","year":"1994","journal-title":"Cytotechnology"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0270","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/A:1007999313566","article-title":"Evaluation of the serum-free medium MDSS2 for the production of poliovirus on Vero cells in bioreactors","volume":"25","author":"Merten","year":"1997","journal-title":"Cytotechnology"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0275","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.bbrc.2005.01.066","article-title":"Transient strong reduction of PTEN expression by specific RNAi induces loss of adhesion of the cells","volume":"328","author":"Mise-Omata","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0280","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant West Nile virus vaccine","volume":"103","author":"Monath","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2019.100009","article-title":"rVSV\u0394G-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire glycoprotein: standardized template with key considerations for a risk\/benefit assessment","volume":"1","author":"Monath","year":"2019","journal-title":"Vaccine X"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0290","first-page":"55","article-title":"The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine","volume":"47","author":"Montagnon","year":"1981","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0188333","article-title":"A universal mammalian vaccine cell line substrate","volume":"12","author":"Murray","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0300","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1242\/jcs.81.1.65","article-title":"Optimization of environment for high density Vero cell culture: effect of dissolved oxygen and nutrient supply on cell growth and changes in metabolites","volume":"81","author":"Nahapetian","year":"1986","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0305","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/(SICI)1097-0290(19960620)50:6<627::AID-BIT3>3.0.CO;2-M","article-title":"Optimization of physical parameters for cell attachment and growth on macroporous microcarriers","volume":"50","author":"Ng","year":"1996","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0310","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.vaccine.2017.03.018","article-title":"Propagation of Brazilian Zika virus strains in static and suspension cultures using Vero and BHK cells","volume":"36","author":"Nikolay","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0315","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/dnares\/dsu029","article-title":"The genome landscape of the African Green monkey kidney-derived Vero cell line","volume":"21","author":"Osada","year":"2014","journal-title":"DNA Res."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0320","doi-asserted-by":"crossref","first-page":"6464","DOI":"10.1016\/j.vaccine.2009.06.020","article-title":"Suspension-Vero cell cultures as a platform for viral vaccine production","volume":"27","author":"Paillet","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0325","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1016\/j.vaccine.2015.03.077","article-title":"An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures","volume":"33","author":"Pereira","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0330","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.procbio.2010.08.010","article-title":"In situ quantification of microcarrier animal cell cultures using near-infrared spectroscopy","volume":"45","author":"Petiot","year":"2010","journal-title":"Process Biochem."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0335","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1007\/s12010-009-8674-0","article-title":"Rapid screening of serum-free media for the growth of adherent Vero cells by using a small-scale and non-invasive tool","volume":"160","author":"Petiot","year":"2010","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0340","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/bit.22783","article-title":"Kinetic characterization of Vero cell metabolism in a serum-free batch culture process","volume":"107","author":"Petiot","year":"2010","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0345","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10616-011-9421-2","article-title":"Real-time monitoring of adherent Vero cell density and apoptosis in bioreactor processes","volume":"64","author":"Petiot","year":"2012","journal-title":"Cytotechnology"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0350","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1017589526145","article-title":"Characterization of Vero cell growth and death in bioreactor with serum-containing and serum-free media","volume":"35","author":"Quesney","year":"2001","journal-title":"Cytotechnology"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1026185615650","article-title":"Kinetics and metabolic specificities of Vero cells in bioreactor cultures with serum-free medium","volume":"42","author":"Quesney","year":"2003","journal-title":"Cytotechnology"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0360","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12981-017-0179-2","article-title":"Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses","volume":"14","author":"Racine","year":"2017","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13568-014-0025-z","article-title":"Assessment of packed bed bioreactor systems in the production of viral vaccines","volume":"4","author":"Rajendran","year":"2014","journal-title":"AMB Express"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0370","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3181\/00379727-132-34285","article-title":"Biological characteristics and viral susceptibility of an African Green monkey kidney cell line (Vero)","volume":"132","author":"Rhim","year":"1969","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0375","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1016\/j.vaccine.2007.01.086","article-title":"A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions","volume":"25","author":"Rourou","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0380","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00253-009-2064-y","article-title":"A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor","volume":"85","author":"Rourou","year":"2009","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0385","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/btpr.279","article-title":"Development of an animal-component free medium for vero cells culture","volume":"25","author":"Rourou","year":"2009","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0390","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s12010-013-0307-y","article-title":"Development of an in situ detachment protocol of Vero cells grown on Cytodex1 microcarriers under animal component-free conditions in stirred bioreactor","volume":"170","author":"Rourou","year":"2013","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0395","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1016\/j.vaccine.2014.02.040","article-title":"An animal component free medium that promotes the growth of various animal cell lines for the production of viral vaccines","volume":"32","author":"Rourou","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0400","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1016\/j.vaccine.2019.05.092","article-title":"Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media","volume":"37","author":"Rourou","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0405","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41598-017-18934-2","article-title":"Novel endogenous simian retroviral integrations in Vero cells: implications for quality control of a human vaccine cell substrate","volume":"8","author":"Sakuma","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0410","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1128\/JVI.01464-15","article-title":"Engineering enhanced vaccine cell lines to eradicate vaccine-preventable diseases: the polio endgame","volume":"90","author":"van der Sanden","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/biot.201700211","article-title":"Enhanced genome editing tools for multi-gene deletion knock-out approaches using paired CRISPR sgRNAs in CHO cells","volume":"13","author":"Schmieder","year":"2018","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0420","doi-asserted-by":"crossref","first-page":"6996","DOI":"10.1016\/j.vaccine.2019.07.003","article-title":"Development of suspension adapted Vero cell culture process technology for production of viral vaccines","volume":"37","author":"Shen","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0425","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/bit.27315","article-title":"Optimized CRISPR \/ Cas9 strategy for homology - directed multiple targeted integration of transgenes in CHO cells","volume":"117","author":"Shin","year":"2020","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0430","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1016\/j.vaccine.2008.03.077","article-title":"Scalable culture systems using different cell lines for the production of Peste des Petits ruminants vaccine","volume":"26","author":"Silva","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0435","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1016\/j.vaccine.2019.07.009","article-title":"Process intensification for peste des petites ruminants virus vaccine production","volume":"37","author":"Sousa","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0440","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1590\/S1516-89132005000400009","article-title":"Influence of culture conditions on vero cell propagation on non-porous microcarriers","volume":"48","author":"Souza","year":"2005","journal-title":"Braz. Arch. Biol. Technol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0445","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.1016\/j.vaccine.2009.06.023","article-title":"Production of yellow fever virus in microcarrier-based Vero cell cultures","volume":"27","author":"Souza","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0450","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.vaccine.2005.08.055","article-title":"A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses","volume":"24","author":"Spruth","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0455","first-page":"303","article-title":"Development of Vero cell-derived inactivated Japanese encephalitis vaccine","volume":"30","author":"Sugawara","year":"2002","journal-title":"Biol. J. Int. Assoc. Biol. Stand."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0460","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.3748\/wjg.v10.i17.2571","article-title":"A novel process for production of hepatitis a virus in Vero cells grown on microcarriers in bioreactor","volume":"10","author":"Sun","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0465","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bej.2014.12.012","article-title":"Novel konjac glucomannan microcarriers for anchorage-dependent animal cell culture","volume":"96","author":"Sun","year":"2015","journal-title":"Biochem. Eng. J."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0470","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s00253-015-7267-9","article-title":"Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production","volume":"100","author":"Tapia","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0475","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.procbio.2011.11.006","article-title":"Transfer of an adherent Vero cell culture method between two different rocking motion type bioreactors with respect to cell growth and metabolic rates","volume":"47","author":"Thomassen","year":"2012","journal-title":"Process Biochem."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0083374","article-title":"Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals","volume":"8","author":"Thomassen","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0485","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/bit.24798","article-title":"Scale-down of the inactivated polio vaccine production process","volume":"110","author":"Thomassen","year":"2013","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0490","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/j.vaccine.2014.02.022","article-title":"Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods","volume":"32","author":"Thomassen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0495","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/j.vaccine.2009.02.062","article-title":"Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus","volume":"27","author":"Tiwari","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0500","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.biologicals.2007.02.002","article-title":"Japanese encephalitis virus production in Vero cells with serum-free medium using a novel oscillating bioreactor","volume":"35","author":"Toriniwa","year":"2007","journal-title":"Biologicals"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0505","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.enzmictec.2004.11.008","article-title":"Comparison of various culture modes for the production of rabies virus by Vero cells grown on microcarriers in a 2-l bioreactor","volume":"36","author":"Trabelsi","year":"2005","journal-title":"Enzym. Microb. Technol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0510","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jbiotec.2005.07.018","article-title":"Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor","volume":"121","author":"Trabelsi","year":"2006","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0515","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bej.2014.06.001","article-title":"Process intensification for an enhanced replication of a newly adapted RM-65 sheep pox virus strain in Vero cells grown in stirred bioreactor","volume":"90","author":"Trabelsi","year":"2014","journal-title":"Biochem. Eng. J."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0520","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41568-018-0009-4","article-title":"Oncolytic viruses as engineering platforms for combination immunotherapy","volume":"18","author":"Twumasi-Boateng","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0525","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00449-014-1294-2","article-title":"Mathematical model of adherent Vero cell growth and poliovirus production in animal component free medium","volume":"38","author":"Ursache","year":"2015","journal-title":"Bioprocess Biosyst. Eng."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0530","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jviromet.2013.04.020","article-title":"Comparison of initial feasibility of host cell lines for viral vaccine production","volume":"193","author":"Vlecken","year":"2013","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0535","first-page":"1","article-title":"The genome of the vervet (Chlorocebus aethiops sabaeus)","volume":"4","author":"Warren","year":"2015","journal-title":"Genome Res."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0540","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3844\/ajbbsp.2012.81.98","article-title":"Key parameters of measles virus production for oncolytic virotherapy","volume":"8","author":"Weiss","year":"2012","journal-title":"Am. J. Biochem. Biotechnol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0545","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/elsc.201400165","article-title":"Oncolytic measles viruses produced at different scales under serum-free conditions","volume":"15","author":"Weiss","year":"2015","journal-title":"Eng. Life Sci."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0550","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1128\/jcm.28.2.283-286.1990","article-title":"Growth of Vero E-6 cells on microcarriers in a cell bioreactor","volume":"28","author":"White","year":"1990","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0555","first-page":"5","article-title":"Acceptability of cells substrates for production of biologicals","volume":"747","author":"World Health Organization","year":"1987","journal-title":"WHO Tech. Rep. Ser."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0560","first-page":"99","article-title":"Requirements for continuous cell lines used for biologicals substances","volume":"745","author":"World Health Organization","year":"1987","journal-title":"WHO Tech. Rep. Ser."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0565","author":"World Health Organization"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0570","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s004499900156","article-title":"Hydrodynamic shear forces increase Japanese encephalitis virus production from microcarrier-grown Vero cells","volume":"23","author":"Wu","year":"2000","journal-title":"Bioprocess Eng."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0575","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1016\/j.vaccine.2004.05.037","article-title":"Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development","volume":"22","author":"Wu","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0580","article-title":"Inactivated enterovirus 71 vaccine produced by 200-L scale serum-free microcarrier bioreactor system provides cross-protective efficacy in human SCARB2 transgenic mouse","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0585","doi-asserted-by":"crossref","first-page":"170021","DOI":"10.1038\/sdata.2017.21","article-title":"Development of improved vaccine cell lines against rotavirus","volume":"4","author":"Wu","year":"2017","journal-title":"Sci. Data"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0590","first-page":"1201","article-title":"The research for the SV40 by means of tissue culture technique","volume":"21","author":"Yasumura","year":"1963","journal-title":"Nippon Rinsho"},{"key":"10.1016\/j.biotechadv.2020.107608_bb0595","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/bit.10917","article-title":"Rabies virus production in high Vero cell density cultures on macroporous microcarriers","volume":"85","author":"Yokomizo","year":"2004","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2020.107608_bb0600","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10616-006-9030-7","article-title":"A serum-free Vero production platform for a chimeric virus vaccine candidate","volume":"51","author":"Yuk","year":"2006","journal-title":"Cytotechnology"}],"container-title":["Biotechnology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975020301105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975020301105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T11:51:00Z","timestamp":1760010660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0734975020301105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":120,"alternative-id":["S0734975020301105"],"URL":"https:\/\/doi.org\/10.1016\/j.biotechadv.2020.107608","relation":{},"ISSN":["0734-9750"],"issn-type":[{"value":"0734-9750","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vero cell upstream bioprocess development for the production of viral vectors and vaccines","name":"articletitle","label":"Article Title"},{"value":"Biotechnology Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biotechadv.2020.107608","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107608"}}